▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Brian Feroldi

TMFTypeoh

Brian Feroldi has been covering the healthcare and technology industries for The Motley Fool since 2015. Brian's investing strategy is to buy high-quality companies and then let compounding work its magic. See all of his articles here.

Recent Articles by Brian Feroldi

image-by-pictures-of-money-flickr-creative-commons_large

Dec 27, 2016 by Brian Feroldi

3 Best Stocks for Retirees

These three stocks offer investors value, growth, and yield, making them a great choice for retirees.

drugs-and-pills-on-top-of-hundred-dollar-bills_large

Jan 3, 2017 by Brian Feroldi, Keith Speights, Cory Renauer, and George Budwell

4 Biotech Stocks to Buy in January

On the hunt for a biotech bargain as we head into the new year? If so, our team of healthcare experts think these four biotech stocks deserve a closer look.

dividends growth coins stacked higher

Dec 24, 2016 by Brian Feroldi

3 Great Income Stocks That Could Double Their Dividends

These three income stocks have plenty of room left to grow their dividends in the years ahead.

stocks-hold-forever-clock-across-field_large

Dec 23, 2016 by Brian Feroldi

3 Stocks You Can Keep Forever

This Fool believes that The Priceline Group, Mercadolibre, and Proto Labs are ideal long-term holdings.

coins growing

Dec 23, 2016 by Brian Feroldi

Top Growth Dividend Stocks to Buy in 2017

Are you looking for great stocks that offer both growth and income potential? If so, give FactSet Research Systems, Starbucks, and MarketAxess a closer look.

money raining down on man with unbrella

Dec 22, 2016 by Brian Feroldi

These Dividend Stocks Could Double in 2017

Abercrombie & Fitch, Seaspan, and GNC Holdings have been horrific performers in 2016. Could better times lie ahead for these dividend-paying stocks?

hires-miseq-with-scientist

Dec 20, 2016 by Brian Feroldi

Illumina Has Dropped 32% in 2016 -- Is the Bottom Finally in Sight?

It's been a rough year to be an investor in the genetic-testing equipment maker. Are we finally nearing bottom, or could there be more pain ahead?

Scientist looking at microscope cancer research

Dec 20, 2016 by Brian Feroldi

Why ACADIA Pharmaceuticals Inc. Is Soaring Today

Shares jump in response to the company reporting upbeat clinical data from an important Phase 2 trial.

drugs money

Dec 19, 2016 by Brian Feroldi

ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?

It's been a rough year for investors in the commercial-stage biopharma, but here's why a turnaround could be in the cards.

piles of money near a sand timer

Dec 19, 2016 by Brian Feroldi, Sean Williams, Dan Caplinger, Tyler Crowe, Daniel Miller, Matt DiLallo, and Steve Symington

7 Top Stocks We're Excited About Headed Into 2017

On the hunt for a few great stocks to buy as we head into the new year? Our team of experts thinks that these seven companies deserve a closer look.

money raining down on man with unbrella

Dec 19, 2016 by Brian Feroldi

These 3 Stocks Are Up Over 500% Over the Last 5 Years

It's been a great half-decade to be an investor in these three stocks.

discount on sale

Dec 18, 2016 by Brian Feroldi

3 Unbelievably Undervalued Dividend Stocks

Brookfield Property Partners, Ford, and Gamestop are currently trading for absurdly cheap prices.

checklist

Dec 18, 2016 by Brian Feroldi

Does Visa Pass Warren Buffett's Test?

How does the payment processing giant stack up against Buffett's acquisition criteria?

business man giving thumbs up

Dec 16, 2016 by Brian Feroldi

Here's Why TherapeuticsMD Inc. Is Soaring Today

Shares jump in response to bullish new coverage by an analyst firm.

GettyImages-615246384

Dec 16, 2016 by Brian Feroldi

Where to Invest Money in 2017: 3 Great Ideas

CVS Health, Paycom Software, and Illumina all look like great buys as we prepare for the year ahead.

tearing up contract

Dec 15, 2016 by Brian Feroldi

Here's Why Pacific Biosciences of California Is Collapsing Today

Shares crater in response to the news that Roche has decided to terminate its partnership agreement with the company.

Image by DonkeyHotey via Flickr Creative Commons

Dec 14, 2016 by Brian Feroldi

Warren Buffett's Worst Stocks of 2017

Even the Oracle of Omaha doesn't pick winners 100% of the time.

discount peel revlead

Dec 13, 2016 by Brian Feroldi

3 Beaten-Up Cheap Stocks: Are They Bargains?

These three companies are trading at discounted prices, but are they bargains or value traps?

Dec 13, 2016 by Brian Feroldi

These Growth Stocks Could Double in 2017

The combination of fast growth and a depressed stock price could lead to big gains in 2017.

thumbs down

Dec 12, 2016 by Brian Feroldi

Here's Why Ophthotech Corporation Is Being Obliterated Today

Shares collapse after the company reports disappointing results from two phase 3 clinical trials.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services